/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
State of Nebraska Selects NIC Inc.’s RxGov® as Its New Prescription Drug Monitoring Platform
OLATHE, Kan.–(BUSINESS WIRE)–NIC Inc. (Nasdaq: EGOV), the nation’s leader of innovative digital
government solutions, has been selected to provide its RxGov
prescription drug monitoring platform to the State of Nebraska to help
address prescription opioid issues and further promote patient safety.
The agreement includes a five-year base contract, plus two, one-year
renewals, which could extend it through September 2026. The contract was
awarded to NIC by the regional health information exchange, the Nebraska
Health Information Initiative (NeHII) who will oversee the Nebraska
Prescription Drug Monitoring Program (PDMP) in collaboration with the
Nebraska Department of Health and Human Services.
“The abuse of prescription opioids is a national epidemic, and PDMPs,
like NIC’s RxGov, are just one element of combatting this crisis,” said
Harry Herington, NIC Inc. Chief Executive Officer and Chairman of the
Board. “We appreciate the confidence the Nebraska Health Information
Initiative has placed in us, and we look forward to providing expanded
capabilities of RxGov to the State of Nebraska.”
RxGov will be used according to the unique laws of the State of
Nebraska, which require recording and storing data from all
prescriptions, not just controlled substances. NIC will be working with
a larger and more complex set of data and requirements, as well as
supporting the emerging national standard for interstate data sharing,
RxCheck.
“The RxGov platform will further enhance the state’s prescription drug
monitoring program to provide a comprehensive tool for medical providers
in Nebraska to care for and monitor the treatment of their patients,”
said Jaime Bland, CEO, NEHII. “The new PDMP enhancements will support
interstate data sharing, ensure ease of access to providers, improve
provider workflow, and continue to deliver a thorough view of a
patient’s prescription history helping medical providers in their
clinical decision making.”
NIC has been providing PDMP systems and related technology since 2011 in
Montana and more recently in Wisconsin and Utah. RxGov currently serves
as the PDMP system for the state of Maryland, in partnership with the
Chesapeake Regional Information System for our Patients (CRISP).
In addition to the new contract to provide its RxGov solution, NIC has
been partnering with the State of Nebraska since 1995 to provide digital
government services. The Company has a local team in Lincoln, Neb., that
has developed a number of solutions to help citizens and businesses more
easily interact with government.
About NIC
NIC Inc. (Nasdaq: EGOV) launched the digital government industry in
1992, and continues to lead it, providing a secure payment engine and
thousands of digital government solutions across a network of more than
6,000 federal, state, and local government agencies. In addition, NIC is
a leading provider of outdoor recreation solutions, with 1 out of 6
hunting and fishing licenses in the United States sold using an NIC
service. The Company launched the nation’s first personal assistant for
government and comprehensive mobile platform, Gov2Go®, as well as the
innovative, data-driven prescription drug monitoring platform, RxGov®.
More information is available at www.egov.com.
Contacts
Jessica Redmond
Corporate Communications
913-754-7054
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III